These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7917679)

  • 1. Issues in cardiac pacing: can agism be justified?
    Payne GE; Skehan JD
    Br Heart J; 1994 Aug; 72(2):102-3. PubMed ID: 7917679
    [No Abstract]   [Full Text] [Related]  

  • 2. Recommendations for pacing.
    Sutton R; Perrins J; Clarke M; Cobbe SM; Charles RG
    BMJ; 1992 Dec; 305(6866):1432. PubMed ID: 1486315
    [No Abstract]   [Full Text] [Related]  

  • 3. Recommendations for pacing.
    Banning AP; Avery PG; McGurk LA; Fraser AG; Buchalter M
    BMJ; 1992 Dec; 305(6866):1431-2. PubMed ID: 1486314
    [No Abstract]   [Full Text] [Related]  

  • 4. Recommendations for pacing.
    Channon KM; Cripps TR; Ormerod O
    BMJ; 1992 Dec; 305(6866):1431; author reply 1432. PubMed ID: 1301052
    [No Abstract]   [Full Text] [Related]  

  • 5. Issues in cardiac pacing; can agism be justified?
    Hargreaves MR; Ormerod O
    Br Heart J; 1995 Jan; 73(1):101. PubMed ID: 7888249
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential costs of cardiac re-synchronisation therapy for chronic heart failure in Scotland.
    Leslie SJ; Paudyal L; Grubb NR; Denvir MA
    Scott Med J; 2005 Nov; 50(4):179-80. PubMed ID: 16374987
    [No Abstract]   [Full Text] [Related]  

  • 7. Reimbursement for cardiac pacing.
    Fyke FE
    Pacing Clin Electrophysiol; 1992 Jul; 15(7):1091-2. PubMed ID: 1378602
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost implications of the British Pacing and Electrophysiology Group's recommendations for pacing.
    de Belder MA; Linker NJ; Jones S; Camm AJ; Ward DE
    BMJ; 1992 Oct; 305(6858):861-5. PubMed ID: 1422398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yes to cardiac devices. But at what cost?
    Leyva F
    Europace; 2013 Mar; 15(3):313-4. PubMed ID: 23243130
    [No Abstract]   [Full Text] [Related]  

  • 10. Report of the policy conference on pacemaker reuse sponsored by the North American Society of Pacing and Electrophysiology.
    Boal BH; Escher DJ; Furman S; Hauser R; Maloney J; Parsonnet V; Raza ST; Tomatis L; Kruse IB; Berstein AD
    J Am Coll Cardiol; 1985 Mar; 5(3):808-10. PubMed ID: 3973281
    [No Abstract]   [Full Text] [Related]  

  • 11. What costs matter? Rethinking social costs of new device technologies.
    Choby AA; Clark AM
    Europace; 2013 Nov; 15(11):1538-9. PubMed ID: 23833047
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial.
    Owen A
    Eur Heart J; 2006 May; 27(9):1125; author reply 1125-6. PubMed ID: 16497689
    [No Abstract]   [Full Text] [Related]  

  • 13. Can an expensive therapy save lives if the disease is not life threatening?
    Wijetunga M; Strickberger SA
    Heart Rhythm; 2005 Mar; 2(3):276. PubMed ID: 15851318
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost effectiveness in health care.
    Tyers GF
    Pacing Clin Electrophysiol; 1997 Jul; 20(7):1890-2. PubMed ID: 9249851
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiac resynchronization therapy for congestive heart failure.
    McAlister F; Ezekowitz J; Wiebe N; Rowe B; Spooner C; Crumley E; Hartling L; Kaul P; Nichol G; Klassen T
    Evid Rep Technol Assess (Summ); 2004 Nov; (106):1-8. PubMed ID: 15612141
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost-effectiveness of physiologic pacing: results of the Canadian Health Economic Assessment of Physiologic Pacing.
    O'Brien BJ; Blackhouse G; Goeree R; Healey JS; Roberts RS; Gent M; Connolly SJ
    Heart Rhythm; 2005 Mar; 2(3):270-5. PubMed ID: 15851317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic and health consequences of managing bradycardia with dual-chamber compared to single-chamber ventricular pacemakers in Italy.
    Deniz HB; Caro JJ; Ward A; Moller J; Malik F
    J Cardiovasc Med (Hagerstown); 2008 Jan; 9(1):43-50. PubMed ID: 18268418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of dual-chamber pacing.
    Parsonnet V
    Eur Heart J; 1996 Apr; 17(4):495-6. PubMed ID: 8733078
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-effectiveness of dual-chamber pacemaker therapy: does single lead VDD pacing reduce treatment costs of atrioventricular block?
    Wiegand UK; Potratz J; Bode F; Schreiber R; Bonnemeier H; Peters W; Katus HA
    Eur Heart J; 2001 Jan; 22(2):174-80. PubMed ID: 11161919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials for cardiac pacing in bradycardia: the end or the beginning?
    Tse HF; Lau CP
    Circulation; 2006 Jul; 114(1):3-5. PubMed ID: 16818826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.